Adiponectin is inversely associated with ratio of serum levels of AGEs to sRAGE and vascular inflammation

International Journal of Cardiology

Volumn 158, Issue 3, 2012, Pages 461-462

  Tahara, Nobuhiro ^a   Yamagishi, Sho Ichi ^a   Tahara, Atsuko ^a   Ishibashi, Masatoshi ^b   Hayabuchi, Naofumi ^b   Takeuchi, Masayoshi ^c   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; AGEs; FDG PET; sRAGE; Vascular inflammation

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18;

ARTERIAL WALL THICKNESS; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; FEMALE; HUMAN; JAPANESE; LETTER; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULITIS;

EID: 84863630553     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.015     Document Type: Article

References (10)

1. S. Rahbar, and J.L. Figarola Novel inhibitors of advanced glycation endproducts Arch Biochem Biophys 419 2003 63 79
2. S. Yamagishi, and T. Imaizumi Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy Curr Pharm Des 11 2005 2279 2299
3. A. Bierhaus, M.A. Hofmann, R. Ziegler, and P.P. Nawroth AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept Cardiovasc Res 37 1998 586 600
4. S.F. Yan, V. D'Agati, A.M. Schmidt, and R. Ramasamy Receptor for advanced glycation endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging Curr Mol Med 7 2007 699 710
5. S. Yamagishi, and T. Matsui Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker Front Biosci (Elite Ed) 2 2010 1184 1195
6. F. Santilli, N. Vazzana, L.G. Bucciarelli, and G. Davì Soluble forms of RAGE in human diseases: clinical and therapeutical implications Curr Med Chem 16 2009 940 952
7. H. Mangge, G. Almer, and M. Truschnig-Wilders Inflammation, adiponectin, obesity and cardiovascular risk Curr Med Chem 17 2010 4511 4520
8. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
9. K. Nakamura, S. Yamagishi, and H. Adachi Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes Diabetes Metab Res Rev 24 2008 109 114
10. N. Tahara, S. Yamagishi, and A. Tahara Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans Atherosclerosis 219 2011 311 315